CQDM, Diazon and the Oncopole in collaboration with Mitacs announce the two laureates of the 2019 Gordon Shore Prize, a mark of excellence for new graduates in life sciences Montreal, May 22, 2019 – CQDM, Diazon Pharmaceuticals, the Oncopole, and Mitacs, are delighted to announce the two laureates of the 2019 Gordon Shore Prize: Rachel…
Unique multi-party collaboration forged to develop new anti-cancer therapies targeting DNA repair regulators Montreal, Canada, May 14, 2019 – The NEOMED Institute (NEOMED), CQDM, the Canadian Cancer Society (CCS), the Goodman Cancer Research Centre (GCRC) and the Lady Davis Institute (LDI) announced today a unique multi-party collaboration to develop new anti-cancer therapies. This collaboration is intended…
Montreal, May 2nd, 2019 – CQDM is pleased to announce that Professor Philippe Gros from McGill University has been awarded $1.5 million as part of the SynergiQC program to pursue the development and validation of new inhibitors of ubiquitin-specific protein protease (USP-15) and its partner TRIM25, that plays a key role in neuroinflammation-based disorders. From this…
Two antigens are targeted in combination with the DPX technology developed by IMV Quebec City, Quebec, March 18, 2019 – IMV Inc. (IMV) (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Canadian bioresearch consortium CQDM has awarded a grant to a collaboration among IMV, Centre de recherche du CHU de Québec-Université…
Created by CQDM, Diazon Pharmaceuticals, the Oncopole, and Mitacs, the Gordon Shore Prize is awarded to new graduates whose masters or doctoral thesis demonstrated their research excellence in the life science field. A 6-month post-diploma internship of $24,000 will be offered to each of the awardees by the participating Quebec-based companies: SpecificiT Pharma Inc., Immune Biosolutions…
Montreal, January 29th, 2019. – CQDM is pleased to announce the appointment of Philippe Walker as a member of CQDM’s Scientific Advisory Board. Philippe already knows CQDM very well since he has contributed very closely to its creation and success. Philippe has over 30 years of experience in pharmaceutical research and development in several therapeutic…
Private companies based in Quebec with life sciences-related activities are invited to offer two 6-month post-diploma internship positions for new graduates (Masters and PhD), future awardees of the Gordon Shore Prize. The Funders of this award, CQDM, Diazon, the Oncopole and Mitacs will finance 50 % of these post-diploma internships. The company must agree to…
Montreal, Quebec – November 19, 2018 – CQDM is delighted to announce that Merck Canada, a founding member of the consortium, is renewing its commitment with a $3.5M contribution to support the development of disruptive technologies in biopharmaceutical research in Quebec and Canada. The research and development projects funded as part of this initiative will…
A first project led by Professor Brian Chen at the Research Institute of the McGill University Health Centre is selected for funding thanks to the Pfizer contribution Montreal, November 19, 2018 – We are pleased to announce that Pfizer Canada, a founding member of CQDM, renews its confidence in CQDM with a contribution of $550,000.…
Montreal, November 19th 2018 – CQDM is pleased to welcome Amgen as a new member of its biopharmaceutical research consortium established to identify and invest in highly innovative biopharmaceutical research projects in Quebec and Canada with the ultimate goal of enabling the development of better treatments for patients. This announcement was made at CQDM’s 10th…